Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 May 14:350:h2145.
doi: 10.1136/bmj.h2145.

Physical activity for smoking cessation in pregnancy: randomised controlled trial

Affiliations
Randomized Controlled Trial

Physical activity for smoking cessation in pregnancy: randomised controlled trial

Michael Ussher et al. BMJ. .

Abstract

Objective: To determine the effectiveness of a physical activity intervention for smoking cessation during pregnancy.

Design: Parallel group, randomised controlled, multicentre trial.

Setting: 13 hospitals in England, April 2009 to January 2014.

Participants: 789 pregnant smokers, aged 16-50 years and at 10-24 weeks' gestation, who smoked at least one cigarette daily and were prepared to quit smoking one week after enrollment were randomised (1:1); 785 were included in the intention to treat analyses, with 392 assigned to the physical activity group.

Interventions: Interventions began one week before a target quit date. Participants were randomised to six weekly sessions of behavioural support for smoking cessation (control) or to this support plus 14 sessions combining supervised treadmill exercise and physical activity consultations.

Main outcome measures: The primary outcome was continuous smoking abstinence from the target quit date until end of pregnancy, validated by exhaled carbon monoxide or salivary cotinine levels. To assess adherence, levels of moderate-vigorous intensity physical activity were self reported and in a 11.5% (n=90) random subsample of participants, physical activity was objectively measured by an accelerometer.

Results: No significant difference was found in rates of smoking abstinence at end of pregnancy between the physical activity and control groups (8% v 6%; odds ratio 1.21, 95% confidence interval 0.70 to 2.10). For the physical activity group compared with the control group, there was a 40% (95% confidence interval 13% to 73%), 34% (6% to 69%), and 46% (12% to 91%) greater increase in self reported minutes carrying out physical activity per week from baseline to one week, four weeks, and six weeks post-quit day, respectively. According to the accelerometer data there was no significant difference in physical activity levels between the groups. Participants attended a median of four treatment sessions in the intervention group and three in the control group. Adverse events and birth outcomes were similar between the two groups, except for significantly more caesarean births in the control group than in the physical activity group (29% v 21%, P=0.023).

Conclusion: Adding a physical activity intervention to behavioural smoking cessation support for pregnant women did not increase cessation rates at end of pregnancy. During pregnancy, physical activity is not recommended for smoking cessation but remains indicated for general health benefits. Trial registration Current Controlled Trials ISRCTN48600346.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; in the past three years PA has done one day of consultancy for Pfizer concerning general smoking cessation advice and not about particular products, and RW has undertaken research and consultancy for companies (Pfizer and GlaxoSmithKline) that develop and manufacture smoking cessation drugs in the past three years; in the past three years TC has been paid for speaking at two educational events that were part or wholly sponsored by a company (Pierre Fabre Laboratories, France) that manufactures nicotine replacement therapy; RW is an unpaid trustee of the stop smoking charity QUIT and an unpaid director of the National Centre for Smoking Cessation and Training; no other relationships or activities that could appear to have influenced the submitted work.

Figures

None
Fig 1 Flow of participants through trial. Participants lost to follow-up included women who experienced fetal or infant loss and were not assessed for smoking status
None
Fig 2 Comparison of self reported levels of moderate-vigorous physical activity (MVPA) in trial groups at different time points. Prediction on log scale from mixed effect model

Comment in

References

    1. Kallen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 2001;11:329-33. - PubMed
    1. Rogers JM. Tobacco and pregnancy. Reprod Toxicol 2009;28:152-60. - PubMed
    1. Salihu HM, Wilson RE. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev 2007;83:713-20. - PubMed
    1. NHS Information Centre. Infant feeding survey 2010: early results. NHS Information Centre for Health and Social Care, 2011.
    1. Tong VT, Dietz PM, Morrow B, et al. Trends in smoking before, during, and after pregnancy—pregnancy risk assessment monitoring system, United States, 40 sites, 2000-2010. MMWR Surveill Summ 2013;62:1-19. - PubMed

Publication types

MeSH terms

Associated data